Effects of efflux pump inhibitors phenyl-arginine-beta-naphthylamide and 1-(1-naphthylmethyl)-piperazine on the antimicrobial susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Coban
A Y
AY
Tanriverdi Cayci
Y
Y
Erturan
Z
Z
Durupinar
B
B
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000382:microbiology*; D004151:Dipeptides / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D010879:Piperazines / Q000494:pharmacology*; D011552:Pseudomonas Infections / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification
C511391:1-(1-naphthylmethyl)piperazine; D000900:Anti-Bacterial Agents; D004151:Dipeptides; D010879:Piperazines; C419365:phenylalanine arginine beta-naphthylamide